TSE:4503 stock news
This page provides real-time market news, earnings updates, and company announcements related to Astellas Pharma Inc. (TSE:4503).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-26 19:32 JST
Vir Biotechnology Stock Hits 52-Week High Tuesday - Here's Why
Finviz2026-02-24 11:12:08
What's Going On With Kyntra Bio Stock Tuesday?
Finviz2026-02-24 13:27:44
Today's Pre-Market Movers and Top Ratings | AMD, HIMS, INTU and More
moomoo-证劵2026-02-24 13:33:52
IRWD Q4 Earnings and Revenues Fall Shy of Estimates, Stock Tanks
Finviz2026-02-26 16:42:04
Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM
Finviz2026-03-01 09:30:11
Pfizer Inc. (PFE) and Astellas Report Positive Phase 3 EV-304 Results for PADCEV Plus Keytruda in Bladder Cancer
Finviz2026-03-04 05:51:43
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
Finviz2026-03-04 13:03:46
Will Linzess Keep Boosting IRWD's Revenue in 2026 Following a Weak Fourth Quarter?
101 finance2026-03-06 14:30:47
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-16 20:09:45
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
Finviz2026-03-23 11:18:54
Ocugen's Dose Dilemma: A Risky Bet on Gene Therapy Clarity
101 finance2026-03-23 11:33:56
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-23 20:09:49
STRO Revenue Falls 21% Yet Cash Runway Stretched to 2028
101 finance2026-03-24 03:39:45
Pfizer Faces Regulatory Hurdle as $36 Target Hinges on Early Prostate Cancer Label Expansion
101 finance2026-03-24 15:18:35
Ocugen's OCU410 Does Not Show a Definitive Dose Response, Creating a Significant Anticipation Gap Ahead of 2028
101 finance2026-03-24 16:51:39
Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM
Finviz2026-03-01 09:30:11
Pfizer Inc. (PFE) and Astellas Report Positive Phase 3 EV-304 Results for PADCEV Plus Keytruda in Bladder Cancer
Finviz2026-03-04 05:51:43
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
Finviz2026-03-04 13:03:46
Will Linzess Keep Boosting IRWD's Revenue in 2026 Following a Weak Fourth Quarter?
101 finance2026-03-06 14:30:47
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-16 20:09:45
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
Finviz2026-03-23 11:18:54
Ocugen's Dose Dilemma: A Risky Bet on Gene Therapy Clarity
101 finance2026-03-23 11:33:56
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-23 20:09:49
STRO Revenue Falls 21% Yet Cash Runway Stretched to 2028
101 finance2026-03-24 03:39:45
Pfizer Faces Regulatory Hurdle as $36 Target Hinges on Early Prostate Cancer Label Expansion
101 finance2026-03-24 15:18:35
Ocugen's OCU410 Does Not Show a Definitive Dose Response, Creating a Significant Anticipation Gap Ahead of 2028
101 finance2026-03-24 16:51:39
TSE:4503 stock price change
On the last trading day, TSE:4503 stock closed at 2525.50 JPY, with a price change of 1.61% for the day.
Trade stock perpsTSE:4503 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more